A carregar...
Randomised assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis
BACKGROUND: Imatinib, a tyrosine kinase inhibitor, has been shown to restore blood–brain barrier integrity and reduce infarct size, haemorrhagic transformation and cerebral oedema in stroke models treated with tissue plasminogen activator. We evaluated the safety of imatinib, based on clinical and n...
Na minha lista:
| Publicado no: | J Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5573589/ https://ncbi.nlm.nih.gov/pubmed/27862464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/joim.12576 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|